ProPhase Labs, Inc. Common Stock (DE)

Go to ProPhase Labs, Inc. Common Stock (DE) Website

$0.31

0.00 (-0.36%)
Live
Previous Close

$0.3076

Day Range

$0 - $0

Previous Day Range

$0.303 - $0.32

Market Cap

$12.9 million USD

Day Vol.

0

Previous Day Vol.

476957

Currency

USD

Primary Exchange

Nasdaq

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provide...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

ProPhase Labs announced the formation of a Clinical Science Advisory Board to support the commercialization of its BE-Smart molecular test for esophageal disease. The advisory board includes experts in the field and aims to accelerate the regulatory and commercialization pathway for the test.

Related tickers: PRPH.

Read Full Article

ProPhase Labs, Inc. (NASDAQ: PRPH) announced the pricing of its underwritten public offering of 4,170,000 shares of common stock at $0.72 per share, raising approximately $3 million. The company plans to use the net proceeds for working capital and general corporate purposes.

Related tickers: PRPH.

Read Full Article
Trending Tickers

Please sign in to view